|Bid||496.50 x 0|
|Ask||498.20 x 0|
|Day's range||493.95 - 493.95|
|52-week range||349.20 - 549.10|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
INDIANAPOLIS, November 28, 2022--Elevance Health, Inc. (NYSE: ELV) announced today that 21 of its affiliated Medicaid plans are the first in the nation to earn a full three-year accreditation for health equity from the National Committee for Quality Assurance (NCQA). The accreditation demonstrates Elevance Health’s commitment to advancing health equity and prioritizing the whole health needs of entire communities of people who have been historically marginalized, economically and socially.
INDIANAPOLIS, November 16, 2022--As part of their ongoing commitment to equity and providing support for women and women’s health, Elevance Health has partnered with national nonprofit Impact Fitness Foundation to create a fitness and movement space at Herron-Riverside High School, in celebration of the inaugural Elevance Health Women’s Fort Myers Tipoff, a pre-season women’s collegiate basketball tournament.
INDIANAPOLIS, November 09, 2022--Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis C, autoimmune diseases, and rheumatology. This acquisition will help Elevance Health meet the specialty